Compare CPAC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CPAC | OLMA |
|---|---|---|
| Founded | 1949 | 2006 |
| Country | Peru | United States |
| Employees | N/A | N/A |
| Industry | Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 949.3M |
| IPO Year | 2003 | 2020 |
| Metric | CPAC | OLMA |
|---|---|---|
| Price | $12.55 | $10.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $12.90 | ★ $44.89 |
| AVG Volume (30 Days) | 40.6K | ★ 832.8K |
| Earning Date | 04-24-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.23% | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.49 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $19.78 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.25 | $6.65 |
| 52 Week High | $12.74 | $36.26 |
| Indicator | CPAC | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 66.28 | 46.29 |
| Support Level | $11.56 | $9.89 |
| Resistance Level | N/A | $11.36 |
| Average True Range (ATR) | 0.26 | 0.49 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 98.25 | 44.55 |
Cementos Pacasmayo SAA is a Peruvian cement company, and only cement manufacturer serving in the northern region of Peru. It produce, distribute and sell cement and cement-related materials, such as precast products and ready-mix concrete. Its products are mainly used in construction, which has been one of the fastest growing segments of the Peruvian economy in recent years. It also produce and sell quicklime for use in mining operations. It also provide transportation services. It has three operating segments cement, concrete, mortar, pavement and precast; quicklime; and sales of construction supplies. The majority of profit comes from Cement segment. Peru's cement production is into three regions northern region, central region, including Lima's metropolitan area, and southern region.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.